A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases

YP Singh, A Pandey, S Vishwakarma, G Modi - Molecular diversity, 2019 - Springer
Iron plays a vital role in several cellular functions due to its unique physiochemical
properties. Iron concentration increases in the brain with age due to multiple factors …

Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative …

H Zheng, LM Weiner, O Bar-Am, S Epsztejn… - Bioorganic & medicinal …, 2005 - Elsevier
Several novel antioxidant-iron chelators bearing 8-hydroxyoxyquinoline moiety were
synthesized, and various properties related to their iron chelation, and neuroprotective …

Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity …

H Zheng, S Gal, LM Weiner, O Bar‐Am… - Journal of …, 2005 - Wiley Online Library
Iron‐dependent oxidative stress, elevated levels of iron and of monoamine oxidase (MAO)‐
B activity, and depletion of antioxidants in the brain may be major pathogenic factors in …

Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators

T Amit, Y Avramovich‐Tirosh, MBH Youdim… - The FASEB …, 2008 - Wiley Online Library
Dysregulation of brain iron homeostasis is central to early neuropathological events in
Alzhei mer's disease (AD), including oxidative stress, inflam matory processes, amyloid …

[HTML][HTML] Chelators in the treatment of iron accumulation in Parkinson's disease

RB Mounsey, P Teismann - International journal of cell biology, 2012 - ncbi.nlm.nih.gov
Iron is an essential element in the metabolism of all cells. Elevated levels of the metal have
been found in the brains of patients of numerous neurodegenerative disorders, including …

Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa …

O Weinreb, S Mandel, O Bar-Am, T Amit - Journal of neural transmission, 2011 - Springer
It is for these authors a great privilege to dedicate this review article to Moussa Youdim, who
is one of the most imperative pharmacologists and pioneer investigators in the search and …

Multifunctional iron-chelators with protective roles against neurodegenerative diseases

A Nunes, SM Marques, C Quintanova, DF Silva… - Dalton …, 2013 - pubs.rsc.org
The multifactorial nature of Alzheimer's disease (AD), and the absence of a disease
modifying drug, makes the development of new multifunctional drugs an attractive …

[HTML][HTML] Iron metabolism in aging and age-related diseases

Y Tian, Y Tian, Z Yuan, Y Zeng, S Wang, X Fan… - International journal of …, 2022 - mdpi.com
Iron is a trace metal element necessary to maintain life and is also involved in a variety of
biological processes. Aging refers to the natural life process in which the physiological …

[HTML][HTML] New perspectives in iron chelation therapy for the treatment of neurodegenerative diseases

MT Nuñez, P Chana-Cuevas - Pharmaceuticals, 2018 - mdpi.com
Iron chelation has been introduced as a new therapeutic concept for the treatment of
neurodegenerative diseases with features of iron overload. At difference with iron chelators …

[HTML][HTML] An attempt to elucidate the role of iron and zinc ions in development of Alzheimer's and Parkinson's diseases

K Wojtunik-Kulesza, A Oniszczuk… - Biomedicine & …, 2019 - Elsevier
Neurodegenerative disorders are among the most studied issues both in medicine and
pharmacy. Despite long and extensive research, there is no effective treatment prescribed …